Business● LowSep 21 · Sep 21, 2026, 4:20 AM
Chinese biopharma stocks jump as U.S. weighs keeping door open to drug deals
GlobeAlert Desk · curated from CNBC · global
Chinese biopharma stocks rose on Monday after a report that the U.S. may continue to allow most drug licensing deals with Chinese firms.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text. How we score stories.
GlobeAlert context
What the desk knows about this story
Threat level
1 Low
Scored from severity, scale, escalation potential and source agreement. Below the alert threshold.
Sources
1 publisher
Single-source so far. Treat details as unconfirmed until more publishers report.
Category
Business
Not flagged as developing.
More in Business
Business30m agoWoodward Non-GAAP EPS of $2.83 beats by $0.31, revenue of $1.2B beats by $60MSeeking Alpha TechBusiness30m agoHuawei case enters jury deliberations after 2-month battle in US courtroomSouth China Morning PostBusiness31m agoMinimum wage for 2027: Dane revealed one of the most important data to take into account for negotiating the salary increaseInfobae · ArgentinaBusiness32m ago“Disastrous clause”: the president of Acopiadores lambasted the practices of mills and also questioned exportersLa Nación · Argentina